Qubyx Releases Newly Updated PressProof 3.1 to Satisfy Your Creative And Prepress Requirements
05/17/2016

Software for those who expect their working tools (camera, display and printer) to be finely tuned to represent colors in the same way.

Online PR News – 17-May-2016 – Wilmington, DE – Qubyx Software Technologies Inc., a leading technology contributor to the color management and medical imaging fields, today announced a new release of its software PressProof 3.1, a full-featured calibration and profiling solution which enables users to achieve true colors on each of devices like monitors, printers and cameras.

PressProof is ...

- Color calibration for a display
- v2 and v4 ICC profiles for any display
- highest quality ICC output profiles for RGB/CMYK/Monochrome printers
- digital camera profiling

The new version of PressProof 3.1 software introduces optimized overall profiling quality, DDC/CI support on Intel HD graphic cards, Windows 8/10 HighDPI mode support. We are also very excited to introduce you the most requested feature of this year - support of Retina displays!

“When creating the product, our goal was to take the user’s digital workflow to the next level .” - says Mr. Marc Leppla, president of Qubyx. ”No matter whether you are a pro or a novice, if you make creative decisions based on what you see on a monitor, you deserve to have confidence that the monitor is telling you the truth.”

“The success of great prints starts well before ink is put on the paper” - explained application developers at Qubyx. “Printer and camera profiling features are essential on the way to quality and true-to-life prints.”

For more information about PressProof, please visit http://qubyx.com/

Download a free demo at http://qubyx.com/download

About Qubyx

At Qubyx we develop calibration, quality assurance and profiling software for medical imaging and color management industries. Products from Qubyx are trusted by such well-known facilities around the world, like PennMedicine the University of Pennsylvania Health System, USA; Hamad Medical Corporation, Qatar; Uppsala Hospital, Sweden; University of Wisconsin-Madison, USA; University of Arizona, USA and many others.